GlobeNewswire by notified

PhosAgro and Growthpoint Properties Among Big Winners on Institutional Investor's Inaugural Emerging EMEA Executive Team Ranking

Share

NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- PhosAgro and Growthpoint Properties are among several notable firms that took home leading positions across their respective sectors in Institutional Investor's inaugural ranking of the region's best chief executives, top CFOs, investor relations professionals, and investor relations companies.

More than 500 buy-side analysts, asset managers, and sell-side researchers at nearly 300 firms, managing an estimated $272 billion in equities in Emerging EMEA named the best chief executives, top CFOs, investor relations professionals, and investor relations companies across 12 business sectors.

Buy-side analysts, money managers and sell-side researchers at securities firms and financial institutions that cover the region identified up to four companies that excel in up to ten investor relations attributes including:

  • Senior executives are accessible
  • IR team is well informed and empowered to speak authoritatively on the company's behalf
  • Timely and appropriate level of financial disclosure
  • Responds quickly and thoroughly to requests
  • Most constructive conference calls
  • Highest quality of meetings through road shows/reversed road shows/conferences
  • Highest quality of corporate documents and investor kit materials
  • Best commitment to corporate governance
  • Delivers insight and useful reports on ESG/SRI metrics
  • Best website

"Investing in Emerging EMEA is not for the fainthearted, with economic and geopolitical uncertainties amongst some of the many challenges," said Amani Korayeim, Director Sales and Product Development All-EMEA. "But in Institutional Investor's inaugural survey of the global investment community, a strong phalanx of companies and leaders emerge who are excelling at cutting through the challenges, and sharing their companies' vision and strategy with investors." She adds, "Perhaps most encouraging, is the array of sectors and countries represented, from Russia to Egypt, Oil and Gas to Constructions & Real Estate all featuring strongly, suggesting that it really is the excellence of the teams in place to navigate through the uncertainty and engage investors. And lastly, in the absence of an objective quality measure of IR but an increasingly institutionalized IR function in the region, the Emerging EMEA Executive Team Survey results of Institutional Investor, will provide an independent vehicle to inform and benchmark companies' IR strategy and continue to help optimize their outreach."

Top Performing Companies and their Sectors Include:

PhosAgro (Russia) Chemicals
Growthpoint Properties (South Africa) Construction & Real Estate
Lenta (Russia) Consumer
Sberbank of Russia (Russia) Financials
NMC Health (United Arab Emirates) Health Care & Pharmaceuticals
El Sewedy Electric Co. (Egypt) Industrials
Severstal (Russia) Metals & Mining
Novatek (Russia) Oil & Gas
Mondi (South Africa) Paper & Forestry
Yandex (Russia) Technology, Media & Telecommunications
Aeroflot (Russia) Transportation
CEZ (Czech Republic) Utilities

Top Performing CEOs and their Sectors Include:

Christopher Griffith Anglo American Platinum (South Africa)
Mohamed Shameel Aziz-Joosub Vodacom Group (South Africa)
Mustafa Sani Sener TAV Havalimanlari Holding (Turkey)
Carlo Palasciano Villamagna Enel Russia (Russia)

Top Performing CFOs and their Sectors Include:

Paul Victor Sasol (South Africa)
Khaled Hassan Cleopatra Hospital Co. (Egypt)
Mustafa Gorkem Elverici Turkiye Sise ve Cam Fabrikalari (Turkey)
Mikhail Stiskin Polyus (Russia)
Alexey Kornya Mobile TeleSystems (Russia)

For the full list of published winners, please visit www.institutionalinvestor.com.

A total of 473 companies were nominated in this year's Emerging EMEA Executive Team rankings. Of those companies, 36 scored high enough to earn the distinction of Most Honored Company in the full sector rankings and 64 earned the Honored Company distinction.

For more information, please contact Amani Korayeim at amani.korayeim@institutionalinvestor.com  or + 44 207 779 8535.

To share your success in your website content, advertisements, communications, and marketing collateral, please contact PARS International Corp. online at www.ii-licensing.com

About  Institutional Investor
For 51 years Institutional Investor has consistently distinguished itself among the world's foremost media companies with groundbreaking journalism and incisive writing that provides essential intelligence for a global audience. In addition, Institutional Investor offers a host of proprietary research and rankings that serve as respected industry benchmarks. For more information visit institutionalinvestor.com.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Institutional Investor News via Globenewswire

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

DSV, 1103 - INTERIM FINANCIAL REPORT Q1 202424.4.2024 07:30:53 CEST | Press release

Company Announcement No. 1103 Selected key figures and ratios for the period 1 January – 31 March 2024 Q1 2024Q1 2023Key figures (DKKm)Revenue38,34040,954Gross profit10,26511,391Operating profit (EBIT) before special items3,6414,672Profit for the period2,3933,287Adjusted earnings for the period2,4633,340RatiosConversion ratio35.5%41.0%Diluted adjusted earnings per share of DKK 1 for the last 12 months55.376.9 Jens H. Lund, Group CEO: “In a normalising market, we are off to a good start delivering strong financial results in the first quarter of 2024, and I am particularly satisfied that we are gaining market shares in all three divisions. We have also completed the leadership changes, the organisation has settled, and together with the new and experienced leadership team we will concentrate our efforts on executing on our strategy, with particular focus on our customers.” Outlook for 2024 We maintain our outlook for 2024 as announced in the 2023 Annual Report: Operating profit (EBIT) b

Ringkjøbing Landbobanks kvartalsrapport for 1. kvartal 202424.4.2024 07:30:00 CEST | pressemeddelelse

Nasdaq Copenhagen London Stock Exchange Euronext Dublin Øvrige interessenter 24. april 2024 Ringkjøbing Landbobanks kvartalsrapport for 1. kvartal 2024 Bankens bestyrelse og direktion har i dag godkendt kvartalsrapporten for 1. kvartal 2024. Banken realiserer i årets første kvartal et basisresultat på 793 mio. kroner og et resultat efter skat på 616 mio. kroner. Resultatet efter skat forrenter egenkapitalen med 24% p.a. Basisresultat (mio. kroner)1. kvartal 20241. kvartal 20232023202220212020Basisindtjening i alt1.0408493.8282.8622.4332.179Samlede udgifter og afskrivninger247227963891817788Basisresultat før nedskrivninger på udlån7936222.8651.9711.6161.391Nedskrivninger på udlån m.v.0-1-1-2-68-223Basisresultat7936212.8641.9691.5481.168Beholdningsresultat m.v.+23-21-7-69+7-9Af- og nedskrivninger på immaterielle aktiver5520201715Skat195140682385309224Resultat efter skat6164552.1551.4951.229920 1. kvartal 2024 i overskrifter Resultatet efter skat udgør 616 mio. kroner, hvilket forrenter e

Ringkjøbing Landbobank’s quarterly report for the first quarter of 202424.4.2024 07:30:00 CEST | Press release

Nasdaq Copenhagen London Stock Exchange Euronext Dublin Other stakeholders 24 April 2024 Ringkjøbing Landbobank’s quarterly report for the first quarter of 2024 The bank’s board of directors and general management today approved the quarterly report for the first quarter of 2024. The bank delivers core earnings of DKK 793 million and net profit of DKK 616 million in the first quarter of the year. The net profit is equivalent to a 24% p.a. return on equity. Core earnings (DKK million)Q1 2024Q1 20232023202220212020Total core income1,0408493,8282,8622,4332,179Total expenses and depreciation247227963891817788Core earnings before impairment charges for loans7936222,8651,9711,6161,391Impairment charges for loans etc.0-1-1-2-68-223Core earnings7936212,8641,9691,5481,168Result for the portfolio etc.+23-21-7-69+7-9Amortisation and write-downs on intangible assets5520201715Tax195140682385309224Net profit6164552,1551,4951,229920 Highlights of the first quarter of 2024 The net profit is DKK 616 mi

Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarter24.4.2024 07:00:00 CEST | Press release

Borregaard’s operating revenues reached NOK 1,975 million (NOK 1,850 million)2 in the 1st quarter of 2024. EBITDA1 increased to NOK 442 million (NOK 435 million). The result in BioSolutions increased while results in BioMaterials and Fine Chemicals were lower compared with the 1st quarter of 2023. The result in BioSolutions increased due to higher sales volume and reduced energy costs. In BioMaterials, higher sales volume was more than offset by lower sales prices and higher wood costs. Fine Chemicals had a lower result due to low bioethanol deliveries and increased costs. The net currency effects were slightly negative for the Group. Profit before tax was NOK 261 million (NOK 292 million). Earnings per share were NOK 2.01 (NOK 2.32). - We are pleased with the strong result improvement in BioSolutions and the positive sales volume development for the Group, says President and CEO Per A. Sørlie. Contacts: Director Investor Relations, Knut-Harald Bakke, +47 905 79 164 Director Communicat

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-1924.4.2024 07:00:00 CEST | Press release

Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appratioss fn of the Swiranc against most currencies, sales were 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A). Divisional sales growth was 2%, reflecting the impact of the expected decline in sales of the COVID-19 medicine Ronapreve Diagnostics Division base business2 grew by 8%, supported by growth across all regions because of demand for immunodiagnostic products, clinical chemistry tests and advanced staining solutions. As this growth was partially offset by the lower dem

HiddenA line styled icon from Orion Icon Library.Eye